Cameron Hajialiakbar

Cooley advised Vivace Therapeutics, a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, on its $35 million Series D financing.

Cooley advised Talkiatry, a top provider of high-quality, in-network psychiatric care, on its $130 million equity and debt financing round.

Cooley advised Blue Owl Capital, a top asset manager that is redefining alternatives, on its strategic investment – consisting of a nondilutive, nonrecourse royalty-backed loan of up to $140 million – in XOMA Corporation, a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health.

Cooley represented ZitSticka, a skin care brand focused on acne treatments, on its sale to Heyday, a next-generation consumer products company pioneering a digital-first approach to brand building. Partners Nick Hobson and Anne Lieberman led the Cooley team advising ZitSticka.

Cooley advised G2.com, a software review site, on its $157 million Series D financing round, which brings its valuation to $1.1 billion. Lawyers Jon Gavenman and Sepideh Mousakhani led the Cooley team advising G2.com on the round.